SNOA - Sonoma stock soars ~90% on product registration enabling sale to US government

• Sonoma Pharmaceuticals ( NASDAQ: SNOA ) said its Microcyn Rx products have received a Distribution and Pricing Agreement (DAPA) for distribution by the Defense Logistics Agency (DLA).
• The DAPA enables Sonoma's partner EMC Pharma to enter into distribution agreements for Microcyn Rx products with federal customers. About half of EMC Pharma's customers are U.S. government entities, the company added.
• The agreement includes Sonoma's Microcyn Rx products including wound care, prescription dermatology products, Celacyn and Levicyn, and prescription eye care Acuicyn.
• "Sales to the U.S government through EMC Pharma represent a new distribution channel for Sonoma increasing the range of customers and regions we sell to," said Sonoma CEO Amy Trombly.
• SNOA +91.75% to $2.30 premarket Jan. 25

For further details see: